Parkinsonism: Differential age-trend in Helicobacter pylori antibody

Alimentary Pharmacology and Therapeutics

Volumn 14, Issue 9, 2000, Pages 1199-1205

  Dobbs, ^a,b,c,d   Charlett, ^a,b,c   Weller, ^a,b,c   Peterson, ^a,b,c  

^a ST MARK S HOSPITAL   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

^c UNIVERSITY OF HERTFORDSHIRE   (United Kingdom)

^d NONE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; IMMUNOGLOBULIN G ANTIBODY;

ADULT; AGED; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ERADICATION THERAPY; FEMALE; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HOST SUSCEPTIBILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PARKINSONISM; PEPTIC ULCER; PRIORITY JOURNAL; SEROPREVALENCE;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ANTIBODIES, BACTERIAL; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HELICOBACTER PYLORI; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; MODELS, STATISTICAL; PARKINSON DISEASE; SEROLOGIC TESTS; SOCIAL CLASS; UREASE;

EID: 0033806955     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2000.00815.x     Document Type: Article

References (59)

1. Symptomatology and medical treatment of Parkinson's disease
2. The association of gastro-duodenal ulceration with Parkinson's disease
3. Dopamine disorder in duodenal ulceration
4. Activity of selective dopamine DA1 and DA2 agonists and antagonists on experimental gastric lesions and gastric acid secretion
5. Monoamine oxidase B inhibition reduces gastric mucosal blood flow, basal acid secretion, and cold water restraint-induced gastric mucosal injury in rats
6. Dopamine agonists prevent duodenal ulcer relapse
7. Experimental basis for a role for sulfhydryls and dopamine in ulcerogenesis: A primer for cytoprotection-organoprotection
8. Dopamine and gastroprotection. The brain-gut axis
9. Brain-gut relationships: Gastric mucosal defense is also important
10. Gastric Helicobacter pylori infection as a cause of idiopathic Parkinson's disease and non-arteric anterior optic ischemic neuropathy
11. Unidentified curved bacilli on gastric epithelium in active chronic gastritis
12. Link between Helicobacter pylori infection and idiopathic parkinsonism
13. Parkinsonism: Siblings share Helicobacter pylori seropositivity and facets of syndrome
14. Cortisol is higher in parkinsonism and associated with gait deficit
15. Association of circulating TNF-α and IL-6 with ageing and parkinsonism
16. Clinical analysis of the disability of Parkinson's disease
17. Parkinsonism: Onset, progression and mortality
18. Parkinson's disease
19. Parkinsonism - Recognition and differential diagnosis
20. Defining Parkinson's disease and Parkinsonism
21. Modified tooting bec questionnaire
22. Epidemiology of Helicobacter pylori infection among 4742 randomly selected subjects from Northern Ireland
23. Cigarette smoking and Parkinson's disease: 1. A comparison of cases with matched neighbours
24. Epidemiology: Incidence, geographic distribution and genetic considerations
25. The epidemiology of Parkinson's disease
26. Parkinson's disease and the environment in early life
27. Hypothesis: The bradyphrenia of Parkinsonism is a nosological entity
28. Assessment of the bradyphrenia of Parkinsonism: A novel use of delayed auditory feedback
29. Who gets false-negative H. pylori (HP) ELISA results?
30. Gastrointestinal dysfunction in Parkinson's disease: Frequency and pathophysiology
31. Dopaminergic defect of enteric nervous system in Parkinson's disease patients with chronic constipation
32. Parkinson's disease and megacolon: Concentric hyaline inclusions (Lewy bodies) in enteric ganglion cells
33. Is Parkinson's disease acquired or inherited?
34. Familial subsets in idiopathic Parkinson's disease
35. Is Helicobacter pylori antigen responsible for changes in circulating immunoglobulin associated with ageing?
36. Helicobacter pylori infection induces antibodies cross-reacting with human gastric mucosa
37. Molecular mimicry between Helicobacter pylori and the host
38. The cohort effect and Helicobacter pylori
39. Alzheimer's disease, Parkinson's disease, and motoneurone disease: Abiotrophic interaction between ageing and environment?
40. Autoimmunity in Parkinson's disease
41. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains
42. Investigations on auto-antibodies in Alzheimer's and Parkinson's diseases, using defined neuronal cultures
43. γδ+ T cells are increased in patients with Parkinson's disease
44. Immunocytochemical analysis of tumour necrosis factor and its receptors in Parkinson's disease
45. Interleukin-1-beta, interleukin-6, epidermal growth-factor-alpha and transforming growth-factor-alpha are elevated in the brain from parkinsonian patients
46. Parkinson's disease and immunological abnormalities: Increase of HLA-DR expression on monocytes in cerebrospinal fluid and of CD45RO+ T cells in peripheral blood
47. A correlation study between serum adenosine-deaminase activities and peripheral lymphocyte subsets in Parkinson's disease
48. Interleukin (IL)-1 beta, IL-2, IL-4, IL-6 and transforming growth factor-alpha levels are elevated in ventricular cerebrospinal fluid in juvenile parkinsonism and Parkinson's disease
49. Humoral response to hsp 65 and hsp 70 in cerebrospinal fluid in Parkinson's disease
50. Association of serum immunoglobulin subclasses IgA1 and IgA2 with facets of parkinsonism in sufferers and controls
51. Experimental destruction of substantia nigra initiated by Parkinson disease immunoglobulins
52. Intrafamilial clustering of Helicobacter pylori infection
53. Prevalence of Helicobacter pylori infection and related gastroduodenal lesions in spouses of Helicobacter pylori positive patients with duodenal ulcer
54. Reduced axial rotation in the spouses of sufferers from idiopathic parkinsonism
55. Quantification of the cardinal signs of parkinsonism and of associated disability in spouses of sufferers
56. Objective measurement of activation of rigidity: Diagnostic, pathogenetic and therapeutic implications in parkinsonism
57. Could seborrhoeic dermatitis be implicated in the pathogenesis of parkinsonism?